Ikapharmindo Putramas Tbk. (JK:IKPM) — Market Cap & Net Worth
Market Cap & Net Worth: Ikapharmindo Putramas Tbk. (IKPM)
Ikapharmindo Putramas Tbk. (JK:IKPM) has a market capitalization of $18.46 Million (Rp315.03 Billion) as of August 1, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #25319 globally and #542 in its home market, demonstrating a 0.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ikapharmindo Putramas Tbk.'s stock price Rp187.00 by its total outstanding shares 1684662500 (1.68 Billion). See capital reinvestment ratio of Ikapharmindo Putramas Tbk. to understand how much of operating cash flow is reinvested back into capital assets.
Ikapharmindo Putramas Tbk. Market Cap History: 2023 to 2026
Ikapharmindo Putramas Tbk.'s market capitalization history from 2023 to 2026. Data shows growth from $19.74 Million to $18.46 Million (1.57% CAGR).
Ikapharmindo Putramas Tbk. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ikapharmindo Putramas Tbk.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Ikapharmindo Putramas Tbk.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Ikapharmindo Putramas Tbk.'s market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $19.74 Million | $441.14 Billion | $15.34 Billion | 0.00x | 0.00x |
| 2024 | $24.09 Million | $412.07 Billion | $5.01 Billion | 0.00x | 0.00x |
Competitor Companies of IKPM by Market Capitalization
Companies near Ikapharmindo Putramas Tbk. in the global market cap rankings as of August 1, 2026.
Key companies related to Ikapharmindo Putramas Tbk. by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1572 globally with a market cap of $15.56 Billion USD ( €13.31 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2161 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2504 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3044 globally with a market cap of $6.34 Billion USD ( R$32.31 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1572 | JD HEALTH INTL LTD | F:8ZN | $15.56 Billion | €4.29 |
| #2161 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2504 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3044 | Raia Drogasil S.A | SA:RADL3 | $6.34 Billion | R$18.48 |
Ikapharmindo Putramas Tbk. Historical Marketcap From 2023 to 2026
Between 2023 and today, Ikapharmindo Putramas Tbk.'s market cap moved from $19.74 Million to $ 18.46 Million, with a yearly change of 1.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp18.46 Million | -16.52% |
| 2025 | Rp22.11 Million | -8.20% |
| 2024 | Rp24.09 Million | +22.00% |
| 2023 | Rp19.74 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Ikapharmindo Putramas Tbk. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.46 Million USD |
| MoneyControl | $18.46 Million USD |
| MarketWatch | $18.46 Million USD |
| marketcap.company | $18.46 Million USD |
| Reuters | $18.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more